MedTrace Logo

Body Composition in Older Adults

NCT06630754 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 30

Last updated 2024-10-08

No results posted yet for this study

Summary

The primary aim of the study is to explore body composition in older adults (aged 70 years and over) with cancer, undergoing systemic anticancer treatment. Additional aims include to explore the extent of body composition changes and whether changes are tumour specific, the incidence for cancer-related cachexia and sarcopenia and finally, how body composition can inform nutritional management of older adults with cancer.

To do this, the investigators applied for and were awarded funding from a company called Nutricia to pay for a band 4 (0.6 WTE for 7 months) to take monthly body composition measures on the patients who are eligible, accepting of assessment by the Senior Adult Oncology Programme (SAOP) and consent to these measures. Measurements will include an analysis from the Bioelectrical Impedance Analysis (BIA) machine which will quantify fat, lean muscle, and water content; waist to hip ratio; handgrip strength; calf circumferences. Socio-demographic data will also be collected.

Descriptive data analysis will take place to explore possible trends and associations which may inform future research and drive even further personalised care for this growing and typically underrepresented in research, population.

Conditions

  • Sarcopenia in Elderly
  • Cachexia; Cancer; Sarcopenia
  • Body Composition Changes
  • Older Adults
  • Nutrition

Interventions

OTHER

No Intervention: Observational Cohort

No intervention; observation cohort study

Sponsors & Collaborators

  • Nutricia UK Ltd

    collaborator INDUSTRY

  • Royal Marsden NHS Foundation Trust

    lead OTHER

Principal Investigators

  • Lucy Eldridge, M.Sc. (Hons) Cancer Care Award · Royal Marsden NHS Foundation Trust

  • Megan Pattwell, PGDip Dietetics · Royal Marsden NHS Foundation Trust

Eligibility

Min Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-11-01
Primary Completion
2025-06-01
Completion
2025-06-01

Countries

  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06630754 on ClinicalTrials.gov